UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 124

Sortiert nach

Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells

Leukemia, 2014-11, Vol.28 (11), p.2155-2164

2014

Volltextzugriff (PDF)

Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma

Oncogene, 2013-10, Vol.32 (42), p.5089-5100

2013

Volltextzugriff (PDF)

A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors

Oncogene, 2007-06, Vol.26 (27), p.3909-3919

2007

Volltextzugriff (PDF)

The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients

Leukemia, 2014-02, Vol.28 (2), p.451-455

2014

Volltextzugriff (PDF)

Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription

Proceedings of the National Academy of Sciences - PNAS, 2002-09, Vol.99 (18), p.11593-11598

2002

Volltextzugriff (PDF)

Axl activates fibroblast growth factor receptor pathway to potentiate survival signals in B-cell chronic lymphocytic leukemia cells

Leukemia, 2016-06, Vol.30 (6), p.1431-1436

2016

Volltextzugriff (PDF)

Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells

Leukemia, 2017-07, Vol.31 (7), p.1658-1658

2017

Volltextzugriff (PDF)

Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma

Oncogene, 2016-11, Vol.35 (47), p.6155-6156

2016

Volltextzugriff (PDF)

Different expression of placental pyruvate kinase in normal, preeclamptic and intrauterine growth restriction pregnancies

Placenta (Eastbourne), 2014-11, Vol.35 (11), p.883-890

2014

Volltextzugriff (PDF)

P-411 Pancreatic cancer oral inverse agonist of RORgT receptor targets primary cancer cells and alters inflammatory mediators of the tumor microenvironment

Annals of oncology, 2023-06, Vol.34, p.S157-S157

2023

Volltextzugriff (PDF)

Transcriptional Repression by YY1 is Mediated by Interaction with a Mammalian Homolog of the Yeast Global Regulator RPD3

Proceedings of the National Academy of Sciences - PNAS, 1996-11, Vol.93 (23), p.12845-12850

1996

Volltextzugriff (PDF)

Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma

British journal of cancer, 2011-11, Vol.105 (10), p.1563-1573

2011

Volltextzugriff (PDF)

Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-xL dependence with alvocidib response

Leukemia, 2014-11, Vol.28 (11), p.2251-2254

2014

Volltextzugriff (PDF)

Sensitization of a Glioblastoma Multiforme (GBM) Cell Line by MP470: A Novel c-Met Antagonist

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S100-S100

2007

Volltextzugriff (PDF)

Mutations in the G-Quadruplex Silencer Element and Their Relationship to c-MYC Overexpression, NM23 Repression, and Therapeutic Rescue

Proceedings of the National Academy of Sciences - PNAS, 2004-04, Vol.101 (16), p.6140-6145

2004

Volltextzugriff (PDF)

Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer

The Journal of biological chemistry, 1998-08, Vol.273 (32), p.20448-20455

1998

Volltextzugriff (PDF)

Telomere maintenance mechanisms as a target for drug development

Oncogene, 2000-12, Vol.19 (56), p.6632-6641

2000

Volltextzugriff (PDF)

A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and Apoptosis

Molecular and Cellular Biology, 1998-01, Vol.18 (1), p.85-92

1998

Volltextzugriff (PDF)

Genetic determinants of response to chemotherapy in transgenic mouse mammary and salivary tumors

Oncogene, 2000-02, Vol.19 (8), p.1114-1122

2000

Volltextzugriff (PDF)

Erratum: Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma

Oncogene, 2016-11, Vol.35 (47), p.6155-6156

2016

Volltextzugriff (PDF)

Erratum: Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells

Leukemia, 2017-07, Vol.31 (7), p.1658-1658

2017

Volltextzugriff (PDF)

Laminin-5 beta 3A Expression in LNCaP Human Prostate Carcinoma Cells Increases Cell Migration and Tumorigenicity

Neoplasia (New York, N.Y.), 2004-10, Vol.6 (5), p.468-479

2004

Volltextzugriff (PDF)

332 POSTER In vivo activity of SGI-1776, an orally active Pim kinase inhibitor

European journal of cancer supplements, 2008, Vol.6 (12), p.105-106

2008

Volltextzugriff (PDF)

341 Targeting NEK2 kinase in drug resistant multiple myeloma with small molecule inhibitors

European journal of cancer supplements, 2010, Vol.8 (7), p.109-109

2010

Volltextzugriff (PDF)

PF285 ZELLA‐101: PHASE 1 STUDY OF ALVOCIDIB FOLLOWED BY 7+3 INDUCTION IN NEWLY DIAGNOSED AML PATIENTS

HemaSphere, 2019-06, Vol.3 (S1), p.94-n/a

2019

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(115)

Publikationsform

Sprache

Englisch
(124)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(68)
Life Sciences & Biomedicine
(61)
Humans
(48)
Animals
(34)
Oncology
(29)
Female
(23)
Biological And Medical Sciences
(19)
Medical Sciences
(18)
Male
(17)
Mice
(16)
Antineoplastic Agents - Pharmacology
(15)
Tumors
(14)
Cell Line, Tumor
(11)
Pharmacology. Drug Treatments
(10)
Adolescent
(9)
Biochemistry & Molecular Biology
(9)
Cancer
(9)
Child
(9)
Gene Expression
(9)
Antineoplastic Agents
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells

Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma

A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors

The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients

Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription

Axl activates fibroblast growth factor receptor pathway to potentiate survival signals in B-cell chronic lymphocytic leukemia cells

Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells

Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma

Different expression of placental pyruvate kinase in normal, preeclamptic and intrauterine growth restriction pregnancies

P-411 Pancreatic cancer oral inverse agonist of RORgT receptor targets primary cancer cells and alters inflammatory mediators of the tumor microenvironment

Transcriptional Repression by YY1 is Mediated by Interaction with a Mammalian Homolog of the Yeast Global Regulator RPD3

Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma

Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-xL dependence with alvocidib response

Sensitization of a Glioblastoma Multiforme (GBM) Cell Line by MP470: A Novel c-Met Antagonist

Mutations in the G-Quadruplex Silencer Element and Their Relationship to c-MYC Overexpression, NM23 Repression, and Therapeutic Rescue

Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer

Telomere maintenance mechanisms as a target for drug development

A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and Apoptosis

Genetic determinants of response to chemotherapy in transgenic mouse mammary and salivary tumors

Erratum: Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma

Erratum: Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells

Laminin-5 beta 3A Expression in LNCaP Human Prostate Carcinoma Cells Increases Cell Migration and Tumorigenicity

332 POSTER In vivo activity of SGI-1776, an orally active Pim kinase inhibitor

341 Targeting NEK2 kinase in drug resistant multiple myeloma with small molecule inhibitors

PF285 ZELLA‐101: PHASE 1 STUDY OF ALVOCIDIB FOLLOWED BY 7+3 INDUCTION IN NEWLY DIAGNOSED AML PATIENTS

Suchergebnisse filtern